Lozinska_2018_Arch.Pharm.(Weinheim)__e1800194

Reference

Title : Donepezil-melatonin hybrids as butyrylcholinesterase inhibitors: Improving binding affinity through varying mode of linking fragments - Lozinska_2018_Arch.Pharm.(Weinheim)__e1800194
Author(s) : Lozinska I , Swierczynska A , Moleda Z , Hartman AM , Hirsch AKH , Czarnocki Z
Ref : Arch Pharm (Weinheim) , :e1800194 , 2018
Abstract :

Hybrid inhibitors of acetyl- and butyrylcholinesterase are compounds that combine structural motifs of two different classical inhibitors, leading to a dual binding ligand. A rapidly growing collection of those compounds involves a wide diversity of structural motifs, but the way of linking two active fragments and its impact on the affinity toward cholinesterases usually remains beyond the extent of investigation. We present hereby a detailed analysis of this aspect using melatonin-donepezil hybrids. A new series of compounds, in which two fragments are connected using a carbamate linker, exhibits excellent activity and selectivity toward butyrylcholinesterase.

PubMedSearch : Lozinska_2018_Arch.Pharm.(Weinheim)__e1800194
PubMedID: 30290008

Related information

Citations formats

Lozinska I, Swierczynska A, Moleda Z, Hartman AM, Hirsch AKH, Czarnocki Z (2018)
Donepezil-melatonin hybrids as butyrylcholinesterase inhibitors: Improving binding affinity through varying mode of linking fragments
Arch Pharm (Weinheim) :e1800194

Lozinska I, Swierczynska A, Moleda Z, Hartman AM, Hirsch AKH, Czarnocki Z (2018)
Arch Pharm (Weinheim) :e1800194